ISSN: 2210-6774 (Online)
ISSN: 2210-6766 (Print)
Volume 6, 4 Issues, 2016
Download PDF Flyer
Instructions for Authors:
Any topic relevant to adolescent development and psychopathology is appropriate for submission to Adolescent Psychiatry. Its primary readership comprises of clinicians who work with adolescents. Authors are welcome to submit abstracts on-line which will be reviewed and authors given feedback regarding the appropriateness of the topic and advisability of submitting a manuscript. Please read the instructions for preparation and submission of manuscripts carefully. Manuscripts that do not conform to these guidelines will be returned to the author for correction before being considered for publication.
Author Form: It is mandatory that a signed Authorship / Copyright / Disclosure / Acknowledgment Form also be submitted along with the manuscript by the corresponding author. Click here to download this form
MANUSCRIPTS SUBMISSION AND REVIEW:
All manuscripts must be submitted electronically to AnnalsEditor@gmail.com with a copy to email@example.com along with a signed Author Form. The editor is happy to provide preliminary feedback as to the appropriateness of a topic for the journal prior to formal submission of a manuscript. Submitted articles that have passed preliminary screening for topicality and readability will undergo blind peer review by at least 3 reviewers. The usual review period is 6 weeks. Papers accepted for publication are typeset and proofs are dispatched to authors for any corrections prior to final publication.
The editorial policies of Bentham Science Publishers on publication ethics, peer-review, plagiarism, copyrights/ licenses, errata/corrections and article retraction/ withdrawal can be viewed here. Bentham Science Publishers uses the iThenticate software to detect instances of overlapping and similar text in submitted manuscripts. iThenticate software checks content against a database of periodicals, the Internet, and a comprehensive article database. It generates a similarity report, highlighting the percentage overlap between the uploaded article and the published material. Any instance of content overlap is further scrutinized for suspected plagiarism according to the publisher’s Editorial Policies. Bentham Science allows an overall similarity of 20% for a manuscript to be considered for publication. For detailed information on the process, see the Publication Policies Page.
Research articles should present data not published elsewhere. Research can be qualitative, quantitative, or mixed methos. Article length can be 4000-8000 words excluding figures, structures, photographs, schemes, tables etc. Each manuscript should clearly state an objective or hypothesis; the design and methods (including the study setting and dates, patients or participants with inclusion and exclusion criteria, or data sources, and how these were selected for the study); the essential features of any interventions; the main outcome measures; the main results of the study; a comment section placing the results in context with the published literature and addressing study limitations; and the conclusions. Data included in research reports must be original.
Reviews of important topics in adolescent psychiatry are accepted as submissions or are solicited by the editor. They should be 8000-9,000 words excluding figures, structures, photographs, schemes, tables etc. Authors should contact the editor prior to submitting a review article. It is important that the review article not duplicate existing reviews and also provide critical appraisal of the literature and identify gaps in knowledge and areas of controversy. Scholarly theoretical papers that address important areas of adolescent development and/or psychopathology are welcomed.
These can cover a variety of topics that are relevant to adolescent mental health. Usual length is 3000 words.
Clinical perspectives may involve case reports or case series, in which the case(s) is/are used to illustrate and discuss a clinical question, or aspect(s) of a disorder. These articles describe clinical manifestations, history, and differential diagnosis, and should include a review of the literature pertaining to the clinical problem, associated psychosocial contributing factors, prognosis, treatment and prevention.
Letters to the Editor:
400 words including references.
Single Topic Issues:
These special issues are peer-reviewed and may contain invited or uninvited review/mini-review articles. A Single Topic Issue Editor will offer a short perspective and co-ordinate the solicitation of manuscripts between 3-5 (for a mini-thematic issue) to 6-10 (for full-length thematic issue) from leading scientists. Authors interested in editing a single topic issue in an emerging topic of outstanding developments in medicinal chemistry and rational drug design may submit their proposal to the Editor-in-Chief at firstname.lastname@example.org for consideration.
The manuscript should be written in English in a clear, direct and active style. Microsoft Word® is the preferred file format for submission of manuscript. Double-space the entire copy, including title page, abstract, list of references, tables, and figure captions in a 10 point font size using Times New Roman 12-point font. The manuscript style must be uniform throughout the text. After the title page, number pages consecutively throughout including the reference pages, tables, and figure legends. Other than for the title page and financial disclosure, blinding is the responsibility of the author. Files should be labeled with appropriate and descriptive file names (e.g. SmithText.doc, SmithFig1.pdf). There is no restriction on the number of figures, tables or additional files e.g. video clips, animation and datasets, that can be included with each article online. Authors should include all relevant supporting data with each article (Refer to Supplementary Material section).
The manuscript file should be uploaded in its native format, such as *.DOC.
Manuscripts with serious deficiencies in English may be returned without review. Our contracted service provider Eureka Science can provide assistance to authors for the preparation of manuscripts, including editing of manuscripts for non-English speaking authors.
MANUSCRIPT SECTIONS FOR PAPERS:
Manuscripts may be divided into the following sections:
- Title page
- List of Abbreviations (if any)
- Conflict of Interest
- Figures/Illustrations (if any)
- Tables (if any)
- Supportive/Supplementary Material (if any)
Title page should include paper title, each author(s) full name and institutional affiliation and location, For multiple authors, place a superscript after each author’s name and indicate the institutional afflilation below. Place an asterisk following the name of the principal/corresponding author, and include the statement.
*Address correspondence to this author at: address, along with phone, fax and email. Please see example.
The abstract of an article should be its clear, concise and accurate summary, having no more than 250 words, and including the explicit sub-headings (as in-line or run-in headings in bold). Use of abbreviations should be avoided and the references should not be cited in the abstract. Ideally, each abstract should include the following sub-headings, but these may vary according to requirements of the article.
FORMATTING OF MANUSCRIPT
Following the introduction, papers should be divided into appropriate sections with headings. For a typical research paper, main headings would be Method, Results and Discussion. For a review article, headings might include Literature Review, Case Examples, Discussion, and Summary. The Discussion section should include implications for clinical practice, recommendations or guidelines, and needs for further study
Level 1 headings (for the main sections) are centered, boldface, with all letters capitalized
Level 2 headings are flush with left margin, boldface, first letter of each word capitalized (title case).
Level 3 headings are indented, boldface, capitalize only the first letter of sentence or phrase, end with a period. These headings are sometimes referred to as paragraph or run-in headings. Although they end with a period (or other punctuation) they need not be complete sentences or grammatically correct.
METHOD (Level 1)
Sample and Participant Selection: (level 2)
The sample consisted of adolescents who presented in our clinic with problem eating. All adolescents and their families who were identified at the time of the initial intake interview as having had problem eating were offered the opportunity to participate in this study. "Problem eating" was defined as a positive reply to the question, "Have you ever been concerned that you (your family member) might have an eating problem."
Assessments and Measures: (level 2)
Family observation protocol. Families were observed eating a meal together in their homes. (Level 3)
Rating scales. The Rating Scale for Family Interaction (Smith, 008) was used to record observations. (Level 3)
The full term for an abbreviation should precede its first appearance in the text unless it is a standard unit of measurement. For example, Borderline personality disorder (BPD) is associated with significant functional impairment. BPD can be difficult to recognize in some patients.
Use the generic term for a drug. When it is necessary to refer to the proprietary name, list it in parentheses after the generic term, followed by the register mark (®).Italics should be used for Binomial names of organisms (Genus and Species), for emphasis and for unfamiliar words or phrases. Non-assimilated words from Latin or other languages should also be italicized e.g. per se, et al. etc.
When material is quoted directly, the original material should be followed exactly, including all punctuation and italics. Quotations must be taken from the edition of the book that is listed in the references. All quoted passages must be followed by source page numbers.
Short quoted passages:
(Fewer than 6 typewritten lines) should be incorporated into the text. The attribution, with the date in parentheses, should, whenever possible, precede the quote as part of the text; the page number, in parentheses, should follow the closing quotation marks, which are followed by the final period, e.g., Freud (1933) wrote, ". . ." (p. 5).
Longer passages should be indented and set off from the rest of the text in a separate paragraph.
Use of his/her:
Wherever possible and reasonable, sexist writing should be avoided by making sentences plural. When speaking of the therapeutic dyad, however, you will have to use singular pronouns. The therapist may always be a female and the patient always male, or vice versa; him or her can be used when doing so doesn't make for too awkward a sentence.
Greek Symbols and Special Characters:
Greek symbols and special characters often undergo formatting changes and get corrupted or lost during preparation of manuscript for publication. To ensure that all special characters used are embedded in the text, these special characters should be inserted as a symbol but should not be a result of any format styling (Symbol font face) otherwise they will be lost during conversion to PDF/XML.
A small paragraph summarizing the contents of the article, presenting the final outcome of the research or proposing further study on the subject, may be given at the end of the article under the Conclusion section.
REFERENCES AND CITATIONS:
All references must be complete and accurate. Use the American Psychological Association style, 6th Edition (London and Washington, DC, 2009, American Psychological Association) as a guide for formatting citations and references. This is a (name, date) system for citations. References are listed alphabetically at the end. A few examples are given below; more examples of the APA style and helpful suggestions for writing may be found on the website of Purdue University (owl.english.purdue.edu/owl/resource/560/01/).
Citations of references in the text
Include the authors' last names and year of publication. For a work with two authors, include both authors' names each time the work is cited. For 3-6 authors, cite all authors the first time the reference occurs; thereafter include only the first author's surname followed by "et al." and the year of publication, e.g., Smith, Brown and Labelle (1990), or (Smith, Brown & Labelle, 1990), then (Smith et al. 1990). For more than 6 authors, use et al. from the first time the work is cited.
Citations should list authors in alphabetical order, for example, (Tang et al. 1987; Tozman & Kamal, 1987). Where two or more references would have the same text citation, add a, b, c, etc. to the year (Smith et al. 1979a; 1979b).
Use an ampersand (&) to join the final name in a citation in parentheses for more than two authors, e.g., (Smith, Labelle & Tang, 2009). However, if the authors are listed in the text as part of a sentence, use "and" as in the following example: "Smith, Labelle and Tang (2009) found …."
When using direct quotations, cite the page number for the quotation along with the source.
References should be double-spaced, in alphabetical order and include the names of all authors for up to 7 authors. For more than seven, list the first 6 authors followed by an ellipsis, then the last author.
The first line of the entry is flush with the left margin, and all subsequent lines are indented (5 spaces or ½") to form a "hanging indent".
For articles accepted for publication, the words "in press" should be substituted for the year.
Personal communications may be cited in the text but are not listed in the references unless they are recoverable as archival materials.
Hutson, H., Anglin, D., Kyriacou, D., Hart, J. & Spears, K. (1995). The epidemic of gang-related homicides in Los Angeles County from 1979 through 1994. Journal of the American Medical Association, 274, 1031-1036.
Curry, G. & Decker, S. (1998). Confronting gangs: Crime and community. Los Angeles, CA: Roxbury.
Gibbs, J.T., & Huang, L.N. (Eds.). (2001). Children of color: Psychological interventions with culturally diverse youth. San Francisco, CA: Jossey-Bass.
No Author or Editor:
Merriam-Webster's collegiate dictionary (11th ed.). (2003). Springfield, MA: Merriam-Webster.
Book Chapters: MUST INCLUDE PAGE NUMBERS
Hammond, K.R., & Adelman, L. (1986). Science, values, and human judgment. In H.R. Arkes & K.R. Hammond (Eds.), Judgment and decision making: An interdisciplinary reader (pp. 127-143). Cambridge: Cambridge University Press.
Meeks, J. (1975). Group delinquent reaction. In Freedman A., Kaplan H. & Sadock B.S. (Eds.), Comprehensive textbook of psychiatry, (2nd ed. Vol. 2, pp. 2136-2142). Baltimore, MD: Williams & Wilkins.
Levine, S. (1999), Wraparound programs: a review of clinical roles, responsibilities, constraints, and possibilities, a report for the County of San Diego Health and Human Services Agency. Unpublished manuscript.
Usually these supply a preferred citation
U.S. General Accounting Office. (1995) School safety: Promising initiatives for addressing school violence. Report to the ranking minority member subcommittee on children and families, committee on labor and human resources (Publication No. GAO/HEHS-95-106). Washington, DC: Author.
Government Report, GPO Publisher:
National Institute of Mental Health. (1990). Clinical training in serious mental illness
(DHHS Publication No. ADM 90-1679). Washington, DC: U.S. Government Printing Office.
Give complete web address
Halsall, P. (1997), Modern history sourcebook: Maximilien Robespierre: Justification of the use of terror. Retrieved from www.fordham.edu/halsall/mod/robespierre-terror.html
Some important points to remember:
- Use References as level one header (capitalize, bold center).
- List references in alphabetical order
- Put spaces after all commas and periods.
- Do not use et al. in references (although it is used in text citations).
- Give starting and ending pages for chapters and journal articles.
- Capitalize only the first word and all proper nouns in titles of works, except for journal names
All authors must strictly follow the guidelines below for preparing illustrations for publication in Adolescent Psychiatry. If the figures are found to be sub-standard, then the manuscripts will be rejected and the authors offered the option of figure improvement professionally by Eureka Science. The costs for such improvement will be charged to the authors.
Illustrations should be provided as separate files, embedded in the text file, and must be numbered consecutively in the order of their appearance. Each figure should include only a single illustration which should be cropped to minimize the amount of space occupied by the illustration.
If a figure is in separate parts, all parts of the figure must be provided in a single composite illustration file.
Photographs should be provided with a scale bar if appropriate, as well as high-resolution component files.
Line Art image type is normally an image based on lines and text. It does not contain tonal or shaded areas. The preferred file format should be TIFF or EPS, with the color mode being Monochrome 1-bit or RGB, in a resolution of 900-1200 dpi.
Halftone image type is a continuous tone photograph containing no text. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 300 dpi.
Combination image type is an image containing halftone, text or line art elements. It should have the preferred file format TIFF, with color mode being RGB or Grayscale, in a resolution of 500-900 dpi.
Illustrations may be submitted in the following file formats:
EPS (preferred format for diagrams)
PDF (also especially suitable for diagrams)
PNG (preferred format for photos or images)
Microsoft Word (version 5 and above; figures must be a single page)
PowerPoint (figures must be a single page)
JPEG (conversion should be done using the original file)
Bentham Science does not process figures submitted in GIF format.
For TIFF or EPS figures with considerably large file size restricting the file size in online submissions is advisable. Authors may therefore convert to JPEG format before submission as this results in significantly reduced file size and upload time, while retaining acceptable quality. JPEG is a ‘lossy’ format. However, in order to maintain acceptable image quality, it is recommended that JPEG files are saved at High or Maximum quality.
Zipit or Stuffit tools should not be used to compress files prior to submission as the resulting compression through these tools is always negligible.
Please refrain from supplying:
- Graphics embedded in word processor (spreadsheet, presentation) document.
- Optimized files optimized for screen use (like GIF, BMP, PICT, WPG) because of the low resolution.
- Files with too low a resolution.
- Graphics that are disproportionately large for the content.
Image Conversion Tools:
There are many software packages, many of them freeware or shareware, capable of converting to and from different graphics formats, including PNG.
General tools for image conversion include Graphic Converter on the Macintosh, Paint Shop Pro, for Windows, and ImageMagick, available on Macintosh, Windows and UNIX platforms.
Bitmap images (e.g. screenshots) should not be converted to EPS as they result in a much larger file size than the equivalent JPEG, TIFF, PNG or BMP, and poor quality. EPS should only be used for images produced by vector-drawing applications such as Adobe Illustrator or CorelDraw. Most vector-drawing applications can be saved in, or exported as, EPS format. If the images were originally prepared in an Office application, such as Word or PowerPoint, original Office files should be directly uploaded to the site, instead of being converted to JPEG or another format of low quality.
- The cost for each individual page of color figures/plates/illustrations is US$ 995. The charge for color illustrations applies to only the print version not online. Authors may submit both a color and black and white version if they wish, with instructions that the color version is to be published online in the black and white print.
- Color figures should be supplied in CMYK and not RGB colors.
- Data Tables should be submitted in Microsoft Word ® table format and should be on separate pages at the end of the manuscript. Each table should be on a separate page. Use decimal tabs to align numbers in tables.
- Place the word Table and the table number above the table, flush left. Place the title of the table (in title case), double-spaced, under the table number, flush left in italics. See the APA manual for more information
- Each table should include an explanatory title/caption with respect to the details discussed in the table. Detailed legends may then follow.
- Table number in bold font i.e. Table 1, should precede a title. The title should be in bold and title case.. A full stop should be placed at the end of the title.
- In the text, refer to the table by its number. Include a notation in the text about where the table or figure should be inserted, for example, <Insert Table 1 about here>.
- Columns and rows of data should be made visibly distinct by ensuring that the borders of each cell are displayed as black lines.
- Tables should be numbered in Arabic numerals sequentially in order of their citation in the body of the text.
- If a reference is cited in both the table and text, please insert a footnote in the table to refer to the reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Place the word Figure and the figure number under the figure, flush left in italics. The title of the figure goes next to the number in sentence case.
We do encourage authors to append supportive material, for example a PowerPoint file containing a talk about the study, a PowerPoint file containing additional screenshots, a Word, RTF, or PDF document showing the original instrument(s) used, a video, or the original data (SAS/SPSS files, Excel files, Access Db files etc.) provided it is endorsed by the journal's Editor. A bibliography of additional resources or recommended reading other than that included in the reference list may also be included with the approval of the Editor.
Supportive/Supplementary material intended for publication must be numbered and referred to in the manuscript but should not be a part of the submitted paper. In-text citations as well as a section with the heading "Supportive/Supplementary Material" before the "References" section should be provided. Here, list all Supportive/Supplementary Material and include a brief caption line for each file describing its contents.
Any additional files will be linked to the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided only on our Web site. Please also make sure that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF files larger than one sheet). Supportive/ Supplementary material must be provided in a single zipped file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication but meant for the reviewers'/editors' perusal only.
Standard Protocol on Approvals, Registrations, Patient Consents & Animal Protection: All clinical investigations must be conducted according to the Declaration of Helsinki principles. Authors must comply with the guidelines of the International Committee of Medical Journal Editors (www.icmje.org/) with regard to the patient's consent for research or participation in a study. Patients' names, initials, or hospital numbers must not be mentioned anywhere in the manuscript (including figures). Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study.
In addition to the standard patient consent for participation in research, authors are responsible for obtaining patient consent-to-disclose forms for all recognizable patients in photographs, videos, or other information that may be published in the Journal, in derivative works, or on the journal's web site and providing the manuscript to the recognizable patient for review before submission. The consent-to-disclose form should indicate specific use (publication in the medical literature in print and online, with the understanding that patients and the public will have access) of the patient's information and any images in figures or videos, and must contain the patient's signature or that of a legal guardian along with a statement that the patient or legal guardian has been offered the opportunity to review the identifying materials and the accompanying manuscript.
A specific declaration of such approval and consent-to-disclose form must be made in the Copyright Letter and in a stand-alone paragraph at the end of the Methods section especially in the case of human studies where inclusion of a statement regarding obtaining the written informed consent from each subject or subject's guardian is a must. The original should be retained by the guarantor or corresponding author. Editors may request to provide the original forms by fax or email.
Randomized Drug Clinical Trial Studies:
Randomized drug clinical trial studies are biomedical or health-related interventional and/or observational research studies conducted in phases in human beings who are randomly allocated to receive or not receive a preventive, therapeutic, or diagnostic intervention that follows a pre-defined protocol. The study is intended to determine the safety and efficacy of approaches to disease prevention, diagnosis and treatment.
Authors of randomized controlled trials are encouraged to submit trial protocols along with their manuscripts. All clinical trials must be registered (before recruitment of the first participant) at an appropriate online public trial registry that must be independent of for-profit interest (e.g., (www.clinicaltrials.gov/). If you wish the editor(s) to consider an unregistered trial, please explain briefly why the trial has not been registered.
- All randomized clinical trials should include a flow diagram and authors should provide a completed randomized trial checklist (see CONSORT Flow Diagram and Checklist; www.consort-statement.org) and a trial protocol.
- Studies of diagnostic accuracy must be reported according to STARD guidelines; (www.stard-statement.org)
- Observational studies (cohort, case-control, or cross-sectional designs) must be reported according to the STROBE statement, and should be submitted with their protocols; (www.strobe-statement.org).
- Genetic association studies must be reported according to STREGA guidelines; (www.medicine.uottawa.ca)
- Systematic reviews and meta-analyses must be reported according to PRISMA guidelines; (www.prisma-statement.org)
- To find the reporting guidelines see (www.equator-network.org)
Important points to remember while submitting clinical trials:
- Trial registry name, registration identification number, and the URL for the registry should be included at the end of the abstract and also in the space provided on the online manuscript submission form. If your research article reports the results of a controlled health care intervention, list the trial registry, along with the unique identifying number (Please note that there should be no space between the letters and numbers of your trial registration number). Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials), are exempted.
- All reports of randomized trials should include a section entitled “Randomization and Masking”, within the Methods section.
- The manuscript must include a statement identifying the institutional and/or licensing committee that has approved the experiments, including any relevant details.
- The SI system of units and the recommended international non-proprietary name (rINN) for drug names must be used. Kindly ensure that the dose, route, and frequency of administration of any drug you mention are correct.
- Please ensure that the clinical trials sponsored by pharmaceutical companies follow the guidelines on good publication practice: (www.gpp-guidelines.org)
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
Greek Symbols and Special Characters:
Greek symbols and special characters often undergo formatting changes and get corrupted or lost during preparation of manuscript for publication. To ensure
that all special characters used are embedded in the text, these special characters should be inserted as a symbol but should not be a result of any format
styling (Symbol font face) otherwise they will be lost during conversion to PDF/XML.
Conflict of Interest:
Financial contributions and any potential conflict of interest must be clearly acknowledged under the heading ‘Conflict of Interest’. Authors must list the source(s) of funding for the study. This should be done for each author.
All individuals listed as authors must have contributed substantially to the design, performance, analysis, or reporting of the work and are required to indicate their specific contribution. Anyone (individual/company/institution) who has substantially contributed to the study for important intellectual content, or who was involved in the article’s drafting the manuscript or revising must also be acknowledged.
Guest or honorary authorship based solely on position (e.g. research supervisor, departmental head) is discouraged.
The specific requirements for authorship have been defined by the International Committee of Medical Journal Editors www.icmje.org Examples of authors' contributions are: 'designed research/study', 'performed research/study', 'contributed important reagents', 'collected data', 'analyzed data', 'wrote paper' etc. This information must be included in the submitted manuscript as a separate paragraph under the heading ‘Acknowledgements’. The corresponding author is responsible for obtaining permission from all co-authors for the submission of any version of the manuscript and for any changes in the authorship.
PERMISSION FOR REPRODUCTION:
Bentham Science has collaborated with the Copyright Clearance Center to meet our customer’s licensing, rights & permission needs.
The Copyright Clearance Center’s RightsLink® service makes it faster and easier to secure permission from Bentham Science journal titles. Simply visit Journals by Title and locate the desired content. Then go to the article’s abstract and click on “Rights and Permissions” to open the RightsLink’s page. If you are unable to locate the content you wish to use or are unable to secure the rights you are seeking, please e-mail us at email@example.com
Published/reproduced material should not be included unless written permission has been obtained from the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of the article for publication.
Authors will receive page proofs of their accepted paper before publications. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Major changes are not acceptable at the proof stage. If unable to send corrections within 48 hours due to some reason, the author(s) must at least send an acknowledgement on receiving the galley proofs or the article will be published exactly as received and the publishers will not be responsible for any error occurring in the published manuscript in this regard.
The corresponding author will be solely responsible for ensuring that the revised version of the manuscript incorporating all the submitted corrections receives the approval of all the co-authors of the manuscript.
Printed reprints and e-prints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: firstname.lastname@example.org
OPEN ACCESS PLUS:
Bentham Science also offers authors the choice of “Open Access Plus” publication of articles at a fee of US$ 450 per article. This paid service allows for articles to be disseminated to a much wider audience, on the terms of the Creative Commons CC BY-NC-ND (Attribution-NonCommercial-NoDerivs) Licence (http://creativecommons.org/licenses/by-nc-nd/4.0/). Authors are asked to indicate whether or not they wish to pay to have their article made more widely available on this “Open Access Plus” basis. Where an author does not opt-in to this paid service, then the author’s article will be published only on Bentham Science’s standard subscription-based access, at no additional cost to the author.
Authors who select the “Quick Track” publication option (see below) and also wish to have their article made available on an “Open Access Plus” basis will be entitled to a 50% discount on the “Open Access Plus” publication fee.
For more information please contact us at e-mail: email@example.com
E-PUB AHEAD OF SCHEDULE:
Bentham Science Publishers are pleased to offer electronic publication of accepted papers prior to scheduled publication. These peer-reviewed papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue. Articles ahead of schedule may be ordered by pay-per-view at the relevant links by each article stated via the E-Pub Ahead of Schedule.
Articles appearing in E-Pub Ahead-of-Schedule sections have been peer-reviewed and accepted for publication in this journal and posted online before scheduled publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Bentham Science Publishers, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained of articles in the E-Pub Ahead-of-Schedule.
Member of Cope